NNovo Nordisk Read More Novo Nordisk Streamlines Operations as Oral Wegovy Data Reinforce Obesity Strategy2026-05-15 Novo Nordisk sells Parkinson’s candidate to focus on metabolic drugs; oral Wegovy shows 21.6% weight loss at 64…